-
Something wrong with this record ?
Urtica dioica extract reduces platelet hyperaggregability in type 2 diabetes mellitus by inhibition of oxidant production, Ca2+ mobilization and protein tyrosine phosphorylation
Mohammed El Haouari, Isaac Jardin, Hasane Mekhfi, Juan A. Rosado, Ginés M. Salido
Language English Country Czech Republic
NLK
Free Medical Journals
from 2003 to 2013
Freely Accessible Science Journals
from 2003 to 2013
ROAD: Directory of Open Access Scholarly Resources
from 2002
- MeSH
- Platelet Aggregation MeSH
- Antioxidants therapeutic use MeSH
- Diabetes Mellitus, Type 2 complications blood therapy MeSH
- Research Support as Topic MeSH
- Phosphorylation physiology MeSH
- Platelet Aggregation Inhibitors therapeutic use MeSH
- Humans MeSH
- Plant Extracts therapeutic use MeSH
- Urtica dioica chemistry drug effects MeSH
- Calcium metabolism MeSH
- Check Tag
- Humans MeSH
Platelet hyperaggregability is involved in the pathogenesis of type 2 diabetes mellitus. Thrombin-evoked platelet aggregation includes the activation of several intracellular pathways, including endogenous generation of reactive oxygen species (ROS), Ca2+ mobilization and protein tyrosine phosphorylation. Here we show that crude aqueous extract from Urtica dioica reduces thrombin-evoked aggregation in platelets from healthy donors and diabetics, in a concentration-dependent manner. U. dioica extract showed a potent antioxidant activity and prevented thrombin-evoked ROS generation in platelets from healthy and diabetic donors. Treatment with U. dioica extract reduced Ca2+ entry induced by thrombin or selective depletion of the two Ca2+ stores in platelets (without altering Ca2+ release), reduced protein tyrosine phosphorylation and reversed the abnormal Ca2+ mobilization and tyrosine phosphorylation in platelets from diabetics. We conclude that extract from U. dioica shows antiaggregant actions and might be used for the treatment and/or prevention of cardiovascular complications associated with type 2 diabetes mellitus.
References provided by Crossref.org
Grant č. SCSS0619 -- Grant č. A/7360/06
Bibliography, etc.Lit.: 28
- 000
- 03226naa 2200457 a 4500
- 001
- bmc07502311
- 003
- CZ-PrNML
- 005
- 20111210121411.0
- 008
- 080306s2007 xr e eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2007.015 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a El Haouari, Mohammed
- 245 10
- $a Urtica dioica extract reduces platelet hyperaggregability in type 2 diabetes mellitus by inhibition of oxidant production, Ca2+ mobilization and protein tyrosine phosphorylation / $c Mohammed El Haouari, Isaac Jardin, Hasane Mekhfi, Juan A. Rosado, Ginés M. Salido
- 314 __
- $a Laboratoire de Physiologie et Ethnopharmacologie, Département de Biologie, Université Mohamed 1er, Faculté des Sciences, Oujda, Morocco
- 500 __
- $a Grant č. SCSS0619 -- Grant č. A/7360/06
- 504 __
- $a Lit.: 28
- 520 9_
- $a Platelet hyperaggregability is involved in the pathogenesis of type 2 diabetes mellitus. Thrombin-evoked platelet aggregation includes the activation of several intracellular pathways, including endogenous generation of reactive oxygen species (ROS), Ca2+ mobilization and protein tyrosine phosphorylation. Here we show that crude aqueous extract from Urtica dioica reduces thrombin-evoked aggregation in platelets from healthy donors and diabetics, in a concentration-dependent manner. U. dioica extract showed a potent antioxidant activity and prevented thrombin-evoked ROS generation in platelets from healthy and diabetic donors. Treatment with U. dioica extract reduced Ca2+ entry induced by thrombin or selective depletion of the two Ca2+ stores in platelets (without altering Ca2+ release), reduced protein tyrosine phosphorylation and reversed the abnormal Ca2+ mobilization and tyrosine phosphorylation in platelets from diabetics. We conclude that extract from U. dioica shows antiaggregant actions and might be used for the treatment and/or prevention of cardiovascular complications associated with type 2 diabetes mellitus.
- 650 _2
- $a Urtica dioica $x chemie $x účinky léků $7 D026982
- 650 _2
- $a rostlinné extrakty $x terapeutické užití $7 D010936
- 650 _2
- $a diabetes mellitus 2. typu $x komplikace $x krev $x terapie $7 D003924
- 650 _2
- $a agregace trombocytů $7 D010974
- 650 _2
- $a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a antioxidancia $x terapeutické užití $7 D000975
- 650 _2
- $a fosforylace $x fyziologie $7 D010766
- 650 _2
- $a finanční podpora výzkumu jako téma $7 D012109
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Jardin, Isaac
- 700 1_
- $a Mekhfi, Hasane
- 700 1_
- $a Rosado, Juan A.
- 700 1_
- $a Salido, Ginés M.
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $g Roč. 5, č. 2 (2007), s. 105-113 $x 1214-021X
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2007/02/08.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 1
- 990 __
- $a 20080306093114 $b ABA008
- 991 __
- $a 20080306135407 $b ABA008
- 999 __
- $a ok $b bmc $g 617931 $s 470363
- BAS __
- $a 3
- BMC __
- $a 2007 $b 5 $c 2 $d 105-113 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $a 2007-22/mkal